首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Comparison of oral and vaginal misoprostol after oral mifepristone in early medical abortion
【24h】

Comparison of oral and vaginal misoprostol after oral mifepristone in early medical abortion

机译:口腔米索前列腺在早期医用流产中口服米糊甾醇的比较

获取原文
           

摘要

Background: Abortions are still a major problem in developing countries contributing to significant maternal morbidity and mortality. WHO has reported that 53 million unplanned pregnancies result in termination each year. One third of these are performed under unsafe conditions. Deaths related to these accounts for up to about 20% of the maternal deaths that occur each year throughout the world. the main objective of the present study is to compare the efficacy, side effects and acceptability of oral and vaginal misoprostol after single oral dose of mifepristone in induction of abortion in pregnancy up to 63 days. Methods: It was a prospective randomized trial of 100 healthy women opting for termination of pregnancy with ultrasound confirmed intrauterine gestation of less than or equal to 9 weeks who were randomized in to two groups. Mifepristone 200mg was administered on day one followed by 800μg of misoprostol orally or vaginally 48 hours later. They were reviewed on day 7 and day 14 by ultrasound for completeness of abortion. If abortion was incomplete or bleeding was excessive, surgical evacuation was performed. Results: The two groups were comparable with respect to age, parity and gestational age. The mean induction abortion interval was 51.2 hours.98% of the women in both the groups had complete abortion. Nausea (68%) and vomiting (58%) were more common in oral group. Diarrhoea (60%) was common in vaginal group. None of them had fever. Mean duration of bleeding was 9 days. 92% of the women found the procedure to be highly acceptable and would recommend it to others. Conclusions: Medical abortion with 200mg mifepristone in combination with 800μg of misoprostol either orally or vaginally 48 hours later was found to be safe, simple, effective, inexpensive, noninvasive and acceptable method.
机译:背景:堕胎仍然是发展中国家有助于显着孕产妇发病率和死亡率的主要问题。谁报告说,5300万只有计划的怀孕会导致每年终止终止。其中三分之一是在不安全的条件下进行的。与这些账户有关的死亡占全世界每年的孕产妇死亡的约20%。本研究的主要目的是比较口服和阴道误解剂在单一口服剂量的米非司酮后诱导妊娠期堕胎后的疗效,副作用和可接受性,最多63天。方法:是一种治疗100个健康妇女的前瞻性随机试验,服用妊娠期终止,超声证实宫内妊娠小于或等于9周,患者分为两组。米非司酮200mg在第一天给予800μg或阴道或阴道后48小时后给药。他们在第7天和第14天通过超声检查堕胎完整性。如果流产不完全或出血过度,则进行外科疏散。结果:两组与年龄,平等和孕龄相当。平均诱导流产间隔为51.2小时.98%的妇女在两个团体中都有完全堕胎。恶心(68%)和呕吐(58%)在口腔群中更常见。腹泻(60%)在阴道组中常见。他们都没有发烧。平均出血的持续时间为9天。 92%的妇女发现该程序是非常可接受的,并会推荐给其他人。结论:与200mg米中代的医疗流产与800μg米索前列蛋酮在口服或阴道48小时后结合,发现是安全的,简单,有效,廉价,无侵蚀性和可接受的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号